{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:40:37Z","timestamp":1790044837106,"version":"4.0.1"},"reference-count":193,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-026-01868-y","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T03:23:41Z","timestamp":1779161021000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Plant-derived neuroprotective compounds and nanoformulations targeting Parkinson\u2019s disease: a semi-systematic review of mechanisms and therapeutic potential"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8354-0699","authenticated-orcid":false,"given":"Saraswathi","family":"Saraswathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0596-7830","authenticated-orcid":false,"given":"Jagadisha Tavarekere","family":"Venkataravanappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaithanya","family":"Nambiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Saji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinuta","family":"Kori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamatha N","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhakara","family":"Somanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh Babu","family":"SV","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun Kumar","family":"Sreeramulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Dayalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindhu Priya","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaithra D Srinivas","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"1868_CR1","doi-asserted-by":"publisher","first-page":"100610","DOI":"10.1016\/j.phyplu.2024.100610","volume":"4","author":"OG Adebayo","year":"2024","unstructured":"Adebayo OG, Adebayo BB (2024) Zingiber officinale extract improves dopaminergic activity in Parkinsonian mice. Phytomed Plus 4:100610","journal-title":"Phytomed Plus"},{"issue":"12","key":"1868_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4103\/0973-7847.99945","volume":"6","author":"H Ahmad","year":"2012","unstructured":"Ahmad H, Sehgal S, Mishra A, Gupta R (2012) Mimosa pudica L. (Laajvanti): An overview. Pharmacogn Rev 6(12):115\u2013124","journal-title":"Pharmacogn Rev"},{"key":"1868_CR3","doi-asserted-by":"crossref","unstructured":"Ahmad N, Ansari MA, Al-Mahmeed A, Joji RM, Saeed NK, Shahid M (2024) Biogenic silver nanomaterials synthesized from Ocimum sanctum leaf extract. Heliyon 10 (15), e35486","DOI":"10.1016\/j.heliyon.2024.e35486"},{"key":"1868_CR4","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1111\/j.1460-9568.2010.07124.x","volume":"31","author":"K Alaerts","year":"2010","unstructured":"Alaerts K, Senot P, Swinnen SP, Craighero L, Wenderoth N, Fadiga L (2010) Force requirements of observed object lifting are encoded by the observer\u2019s motor system: a TMS study. Eur J Neurosci 31:1144\u20131153","journal-title":"Eur J Neurosci"},{"key":"1868_CR5","doi-asserted-by":"publisher","first-page":"153697","DOI":"10.1016\/j.phymed.2021.153697","volume":"91","author":"S Ali","year":"2021","unstructured":"Ali S, Khan MR, Khan A, Khan R (2021) In vitro anticancer activity of oil from Parrotiopsis jacquemontiana. Phytomedicine 91:153697","journal-title":"Phytomedicine"},{"key":"1868_CR6","doi-asserted-by":"crossref","first-page":"116172","DOI":"10.1016\/j.biopha.2024.116172","volume":"171","author":"R AlRuwaili","year":"2024","unstructured":"AlRuwaili R, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Alexiou A, Papadakis M, Abo-El Fetoh ME, Batiha GE-S (2024) Targeting the PI3K\/AKT\/GSK3\u03b2 pathway in Parkinson\u2019s disease: A therapeutic blueprint. Biomed Pharmacother 171:116172","journal-title":"Biomed Pharmacother"},{"key":"1868_CR7","first-page":"274","volume":"49","author":"P Anand","year":"2011","unstructured":"Anand P, Singh B (2011) Neuroprotective effect of herbal drugs in Parkinson\u2019s disease. Indian J Exp Biol 49:274\u2013284","journal-title":"Indian J Exp Biol"},{"key":"1868_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpls.2016.00019","volume":"7","author":"CM Andre","year":"2016","unstructured":"Andre CM, Hausman JF, Guerriero G (2016) Cannabis sativa: the plant of a thousand molecules. Front Plant Sci 7:1\u201317","journal-title":"Front Plant Sci"},{"issue":"10","key":"1868_CR9","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1021\/acsptsci.2c00104","volume":"5","author":"E Angelopoulou","year":"2022","unstructured":"Angelopoulou E, Paudel YN, Papageorgiou SG, Piperi C (2022) Elucidating the beneficial effects of ginger (Zingiber officinale Roscoe) in Parkinson\u2019s disease. ACS Pharmacol Transl Sci 5(10):838\u2013848","journal-title":"ACS Pharmacol Transl Sci"},{"key":"1868_CR10","doi-asserted-by":"publisher","first-page":"100573","DOI":"10.1016\/j.prmcm.2025.100573","volume":"14","author":"R Anjum","year":"2025","unstructured":"Anjum R (2025) Neuroprotective role of traditional Chinese plant extracts on Parkinson\u2019s disease: A comprehensive preclinical review. Pharmacol Res \u2013 Mod Chin Med 14:100573","journal-title":"Pharmacol Res \u2013 Mod Chin Med"},{"issue":"10","key":"1868_CR11","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1166\/jnn.2005.184","volume":"5","author":"B Ankamwar","year":"2005","unstructured":"Ankamwar B, Damle C, Ahmad A, Sastry M (2005) Biosynthesis of gold and silver nanoparticles using Emblica officinalis fruit extract, their phase transfer and transmetallation in an organic solution. J Nanosci Nanotechnol 5(10):1665\u20131671","journal-title":"J Nanosci Nanotechnol"},{"key":"1868_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnut.2022.809621","volume":"9","author":"R Arcusa","year":"2022","unstructured":"Arcusa R, Villa\u00f1o D, Marhuenda J, Cano M, Cerd\u00e0 B, Zafrilla P (2022) Potential role of ginger (Zingiber officinale Roscoe) in the prevention of neurodegenerative diseases. Front Nutr 9:1\u201312","journal-title":"Front Nutr"},{"issue":"24","key":"1868_CR13","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.3390\/plants13243516","volume":"13","author":"R Arya","year":"2024","unstructured":"Arya R, Faruquee HM, Shakya H, Rahman SA, Begum MM, Biswas SK et al (2024) Harnessing antibacterial and anti-carcinogenic properties of Ocimum sanctum Linn (Tulsi). Plants 13(24):3516","journal-title":"Plants"},{"issue":"3","key":"1868_CR14","first-page":"489","volume":"97","author":"S Asha Devi","year":"2005","unstructured":"Asha Devi S, Prasanna S, Subramanyam MVV (2005) Protective effects of Phyllanthus emblica extract on oxidative stress and neuronal damage. J Ethnopharmacol 97(3):489\u2013494","journal-title":"J Ethnopharmacol"},{"issue":"10","key":"1868_CR15","first-page":"8617","volume":"8","author":"N Ayuwardani","year":"2024","unstructured":"Ayuwardani N, Sofro ZM, Fakhrudin N, Ikawati Z (2024) Antioxidant and neuroprotective activities of Phyllanthus emblica L. J Pharmacogn Phytochem 8(10):8617\u20138628","journal-title":"J Pharmacogn Phytochem"},{"key":"1868_CR16","first-page":"65","volume":"639","author":"T Baluchnejadmojarad","year":"2017","unstructured":"Baluchnejadmojarad T, Roghani M, Nadoushan MRJ, Bagheri M (2017) Neuroprotective effect of Emblica officinalis in 6-OHDA-induced Parkinson\u2019s disease model in rats. Neurosci Lett 639:65\u201372","journal-title":"Neurosci Lett"},{"issue":"6","key":"1868_CR18","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0944-7113(00)80030-6","volume":"7","author":"SK Bhattacharya","year":"2000","unstructured":"Bhattacharya SK, Bhattacharya A, Sairam K, Ghosal S (2000) Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: An experimental study. Phytomedicine 7(6):463\u2013469","journal-title":"Phytomedicine"},{"key":"1868_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fnana.2015.00091","volume":"9","author":"J Blesa","year":"2015","unstructured":"Blesa J, Trigo-Damas I, Quiroga-Varela A, Jackson-Lewis VR (2015) Oxidative stress and Parkinson\u2019s disease. Front Neuroanat 9:91","journal-title":"Front Neuroanat"},{"issue":"1","key":"1868_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"ML Block","year":"2007","unstructured":"Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: Uncovering the molecular mechanisms. Nat Rev Neurosci 8(1):57\u201369","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"1868_CR21","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3390\/nu13020602","volume":"13","author":"DA Bonilla","year":"2021","unstructured":"Bonilla DA, Moreno Y, Gho C, Petro JL, Odriozola-Mart\u00ednez A, Kreider RB (2021) Effects of Ashwagandha (Withania somnifera) on physical performance: Systematic review and Bayesian meta-analysis. Nutrients 13(2):602","journal-title":"Nutrients"},{"issue":"6","key":"1868_CR22","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.tins.2017.04.001","volume":"40","author":"HDE Booth","year":"2017","unstructured":"Booth HDE, Hirst WD,Richard Wade-Martins (2017) The role of astrocyte dysfunction in Parkinson\u2019s disease pathogenesis. Trends Neurosci 40(6):358\u2013370","journal-title":"Trends Neurosci"},{"issue":"1","key":"1868_CR23","first-page":"113","volume":"95","author":"EN Bum","year":"2004","unstructured":"Bum EN, Dawack DL, Schmutz M, Rakotonirina A, Rakotonirina SV, Portet C (2004) Anticonvulsant activity of Mimosa pudica decoction in mice. J Ethnopharmacol 95(1):113\u2013117","journal-title":"J Ethnopharmacol"},{"key":"1868_CR24","doi-asserted-by":"crossref","unstructured":"Burns J, Buck AC, Souza D\u2019, Dube S, Bardien A (2023) S., Nanophytomedicines as therapeutic agents for Parkinson\u2019s disease. ACS Omega 8. (45), 42045\u201342061","DOI":"10.1021\/acsomega.3c04862"},{"key":"1868_CR25","first-page":"126","volume":"18","author":"A Cano","year":"2019","unstructured":"Cano A, Turowski M, Ettcheto M, Szperlowska A, Espina M, Garc\u00eda ML, Souto EB (2019) Dual-drug loaded nanoparticles of epigallocatechin-3-gallate and ascorbic acid for protection against Parkinson\u2019s disease. Nanomed Nanotechnol Biol Med 18:126\u2013135","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"1868_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2020.00124","volume":"11","author":"T Cassano","year":"2020","unstructured":"Cassano T, Villani R, Pace L, Carbone A, Bukke VN, Orkisz S et al (2020) From Cannabis sativa to cannabidiol: therapeutic candidate for neurodegenerative diseases. Front Pharmacol 11:1\u201315","journal-title":"Front Pharmacol"},{"issue":"5","key":"1868_CR27","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/jcpt.12179","volume":"39","author":"MHN Chagas","year":"2014","unstructured":"Chagas MHN, Eckeli AL, Zuardi AW, Pena-Pereira MA, Sobreira-Neto MA, Sobreira ET, Camilo MR, Bergamaschi MM, Hallak JEC, Bin-Makhashen S, Tumas V (2014a) Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson\u2019s disease patients: a case series. J Clin Pharm Ther 39(5):564\u2013566","journal-title":"J Clin Pharm Ther"},{"issue":"11","key":"1868_CR28","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1177\/0269881114550355","volume":"28","author":"MHN Chagas","year":"2014","unstructured":"Chagas MHN, Zuardi AW, Tumas V, Pena-Pereira MA, Sobreira ET, Bergamaschi MM et al (2014b) Effects of cannabidiol in patients with Parkinson\u2019s disease. J Psychopharmacol 28(11):1088\u20131098","journal-title":"J Psychopharmacol"},{"key":"1868_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2025.1593191","volume":"16","author":"YH Chang","year":"2025","unstructured":"Chang YH (2025) Curcumin as a potential therapeutic agent for Parkinson\u2019s disease: a systematic review. Front Pharmacol 16:1\u201312","journal-title":"Front Pharmacol"},{"issue":"4","key":"1868_CR30","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1016\/j.foodchem.2012.11.139","volume":"138","author":"AY Chen","year":"2013","unstructured":"Chen AY, Chen YC (2013) A review of the dietary flavonoid, quercetin: Metabolism, bioavailability, and antioxidant properties. Food Chem 138(4):2099\u20132107","journal-title":"Food Chem"},{"issue":"3","key":"1868_CR31","first-page":"839","volume":"55","author":"CY Chen","year":"2007","unstructured":"Chen CY, Wu SL, Huang YC (2007) Anti-inflammatory effects of 6-shogaol and 6-gingerol from Zingiber officinale in lipopolysaccharide-stimulated macrophages. J Agric Food Chem 55(3):839\u2013846","journal-title":"J Agric Food Chem"},{"issue":"6","key":"1868_CR32","first-page":"801","volume":"112","author":"XC Chen","year":"2005","unstructured":"Chen XC, Zhu YG, Zhu LA, Huang C, Chen Y, Chen LM, Fang F (2005) Ginsenoside Rg1 attenuates dopaminergic neuronal loss in a mouse model of Parkinson\u2019s disease. J Neural Transm 112(6):801\u2013811","journal-title":"J Neural Transm"},{"issue":"1","key":"1868_CR33","first-page":"1","volume":"18","author":"X Chen","year":"2023","unstructured":"Chen X, Lu Y, Wang J (2023) Microglia-mediated neuroinflammation in Parkinson\u2019s disease: Mechanisms and therapeutic perspectives. J Neuroimmune Pharmacol 18(1):1\u201318","journal-title":"J Neuroimmune Pharmacol"},{"issue":"4","key":"1868_CR34","doi-asserted-by":"publisher","first-page":"342","DOI":"10.5142\/jgr.2012.36.4.342","volume":"36","author":"IH Cho","year":"2012","unstructured":"Cho IH (2012) Effects of Panax ginseng in neurodegenerative diseases. J Ginseng Res 36(4):342\u2013353","journal-title":"J Ginseng Res"},{"key":"1868_CR35","doi-asserted-by":"crossref","unstructured":"Christensen LP (2008) Ginsenosides. In: Adv Bot Res, pp. 1\u201399","DOI":"10.1016\/S1043-4526(08)00401-4"},{"issue":"16","key":"1868_CR36","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1001\/jama.2014.3654","volume":"311","author":"BS Connolly","year":"2014","unstructured":"Connolly BS, Lang AE (2014) Pharmacological treatment of Parkinson disease: a review. JAMA 311(16):1670\u20131683","journal-title":"JAMA"},{"key":"1868_CR37","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717","journal-title":"Sci Rep"},{"key":"1868_CR38","doi-asserted-by":"crossref","unstructured":"Dalf\u00f3 E, Gim\u00e9nez P, Pall\u00e0s M, Planas JF (2015) Neuroprotective properties of the standardized extract from Camellia sinensis (green tea) and its main bioactive components, epicatechin and epigallocatechin gallate, in the 6-OHDA model of Parkinson\u2019s disease. Oxid. Med. Cell. Longev. 2015, 147826","DOI":"10.1155\/2015\/161092"},{"key":"1868_CR39","first-page":"48","volume":"26","author":"M Deepak","year":"2007","unstructured":"Deepak M, Sarma B (2007) Herbal treatment for Parkinson\u2019s disease: a review. Anc Sci Life 26:48\u201355","journal-title":"Anc Sci Life"},{"key":"1868_CR40","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/JPD-130230","volume":"3","author":"V Dias","year":"2013","unstructured":"Dias V, Junn E, Mouradian MM (2013) The role of oxidative stress in Parkinson\u2019s disease. J Parkinsons Dis 3:461\u2013491","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"1868_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.tins.2006.11.003","volume":"30","author":"Q Ding","year":"2007","unstructured":"Ding Q, Cecarini V, Keller JN (2007) Interplay between protein synthesis and degradation in the CNS. Trends Neurosci 30(1):31\u201336","journal-title":"Trends Neurosci"},{"issue":"5","key":"1868_CR42","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","volume":"68","author":"ER Dorsey","year":"2007","unstructured":"Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68(5):384\u2013386","journal-title":"Neurology"},{"issue":"1","key":"1868_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","volume":"75","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Sherer T, Okun MS, Bloem BR (2018) The emerging evidence of the Parkinson pandemic. JAMA Neurol 75(1):9\u201310","journal-title":"JAMA Neurol"},{"issue":"7","key":"1868_CR44","first-page":"1","volume":"15","author":"A Dubey","year":"2012","unstructured":"Dubey A, Nayak S, Gunjal S (2012) Neuroprotective effects of Ocimum sanctum against oxidative stress and dopaminergic dysfunction in experimental models. J Med Food 15(7):1\u20138","journal-title":"J Med Food"},{"issue":"4","key":"1868_CR45","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","volume":"164","author":"S Duty","year":"2011","unstructured":"Duty S, Jenner P (2011) Animal models of Parkinson\u2019s disease: a source of novel therapeutic targets and drugs. Br J Pharmacol 164(4):1357\u20131391","journal-title":"Br J Pharmacol"},{"key":"1868_CR46","doi-asserted-by":"publisher","first-page":"732","DOI":"10.5530\/ijper.54.3.124","volume":"54","author":"T Duyu","year":"2020","unstructured":"Duyu T, Khanal P, Khatib NA, Patil BM (2020) Mimosa pudica modulates neuroactive ligand\u2013receptor interaction in Parkinson\u2019s disease. Indian J Pharm Educ Res 54:732\u2013739","journal-title":"Indian J Pharm Educ Res"},{"issue":"6","key":"1868_CR47","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nsmb.1437","volume":"15","author":"DE Ehrnhoefer","year":"2008","unstructured":"Ehrnhoefer DE, Bieschke J, Boeddrich A, Herbst M, Masino L, Lurz R, Engemann S, Pastore A, Wanker EE (2008) EGCG redirects amyloidogenic polypeptides into unstructured, non-toxic oligomers. Nat Struct Mol Biol 15(6):558\u2013566","journal-title":"Nat Struct Mol Biol"},{"issue":"7","key":"1868_CR48","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1002\/pca.70020","volume":"36","author":"T Ehtezazi","year":"2025","unstructured":"Ehtezazi T, Sarker SD (2025) Phytochemical nanoparticles for the treatment of neurological disorders. Phytochem Anal 36(7):1918\u20131935","journal-title":"Phytochem Anal"},{"issue":"2","key":"1868_CR49","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0944-7113(99)80044-0","volume":"2","author":"E Elisabetsky","year":"1995","unstructured":"Elisabetsky E, Marshek J, Souza DO (1995) Linalool effects on glutamatergic system and behavioral activity in rodents. Phytomedicine 2(2):107\u2013113","journal-title":"Phytomedicine"},{"issue":"8","key":"1868_CR50","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/sj.bjp.0707337","volume":"151","author":"G Esposito","year":"2007","unstructured":"Esposito G, Scuderi C, Savani C, Steardo L, De Filippis D, Cottone P et al (2007) Cannabidiol blunts \u03b2-amyloid-induced neuroinflammation. Br J Pharmacol 151(8):1272\u20131279","journal-title":"Br J Pharmacol"},{"issue":"5","key":"1868_CR51","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"VL Feigin","year":"2019","unstructured":"Feigin VL, Nichols E, Alam T, Bannick MS, Beghi E, Blake N et al (2019) Global, regional, and national burden of neurological disorders, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(5):459\u2013480","journal-title":"Lancet Neurol"},{"key":"1868_CR52","unstructured":"Feigin VL, Vos T, Nichols E, Owolabi MO, Carroll WM, Dichgans M et al (2024) Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study. BMJ 388, e080952"},{"key":"1868_CR53","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/978-3-319-20825-1_8","volume":"231","author":"J Fern\u00e1ndez-Ruiz","year":"2015","unstructured":"Fern\u00e1ndez-Ruiz J, Romero J, Ramos JA (2015) Endocannabinoids and neurodegenerative disorders. Handb Exp Pharmacol 231:233\u2013259","journal-title":"Handb Exp Pharmacol"},{"issue":"1","key":"1868_CR54","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.brainres.2006.11.063","volume":"1134","author":"M Garc\u00eda-Arencibia","year":"2007","unstructured":"Garc\u00eda-Arencibia M, Gonz\u00e1lez S, de Lago E, Ramos JA, Guaza C, Fern\u00e1ndez-Ruiz J (2007) Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson\u2019s disease: importance of antioxidant and cannabinoid receptor-independent properties. Brain Res 1134(1):162\u2013170","journal-title":"Brain Res"},{"key":"1868_CR55","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.3390\/foods13111774","volume":"13","author":"G Genchi","year":"2024","unstructured":"Genchi G, Lauria G, Catalano A, Carocci A, Sinicropi MS (2024) Neuroprotective effects of curcumin in neurodegenerative diseases. Foods 13:1774","journal-title":"Foods"},{"issue":"6","key":"1868_CR56","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"CK Glass","year":"2010","unstructured":"Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140(6):918\u2013934","journal-title":"Cell"},{"issue":"1","key":"1868_CR57","first-page":"1","volume":"15","author":"R Gordon","year":"2018","unstructured":"Gordon R, Albornoz EA, Christie DC, Langley MR, Adamczak SE, Lane SD, Schiapacassi AC, Vijayakumar SL, O\u2019Neil JD, Akiba Y, Li S, Yerbury JJ, Blair IP, Park H, Cherny RA, Bush AI, Halliday GM, Gupta AS, Reiman EM, Shakespear SK (2018) Inflammasome activation in Parkinson\u2019s disease: A target for neuroprotection. J Neuroinflamm 15(1):1\u201315","journal-title":"J Neuroinflamm"},{"issue":"4","key":"1868_CR58","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1080\/07391102.2012.10507408","volume":"29","author":"A Grover","year":"2012","unstructured":"Grover A, Shandilya A, Agrawal V, Bisaria VS, Sundar D (2012) Inhibitory potential of Withaferin A against JAK1 kinase: a target for Parkinson\u2019s disease. Biomol Struct Dyn 29(4):651\u2013662","journal-title":"Biomol Struct Dyn"},{"key":"1868_CR59","doi-asserted-by":"crossref","first-page":"105498","DOI":"10.1016\/j.fitote.2023.105498","volume":"167","author":"E Guedes","year":"2023","unstructured":"Guedes E, Macedo PT, Ferreira-Vieira TH, de Castro JP, da Silva JKRD, de Oliveira ACP (2023) Cannabis sativa extracts reduce inclusion formation in a cell model of \u03b1-synuclein aggregation. Fitoterapia 167:105498","journal-title":"Fitoterapia"},{"key":"1868_CR60","unstructured":"Guo Y et al (2022) Herbal medicines and natural products for Parkinson\u2019s disease: From basic research to clinical studies. Front. Pharmacol"},{"issue":"11","key":"1868_CR61","first-page":"218","volume":"3","author":"GL Gupta","year":"2007","unstructured":"Gupta GL, Rana AC (2007) Protective effect of Withania somnifera Dunal root extract against prooxidant activity of lead in mice brain. Pharmacogn Mag 3(11):218\u2013222","journal-title":"Pharmacogn Mag"},{"issue":"2","key":"1868_CR62","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.expneurol.2005.01.013","volume":"193","author":"A Hald","year":"2005","unstructured":"Hald A, Lotharius J (2005) Oxidative stress and inflammation in Parkinson\u2019s disease: Is there a link? Exp Neurol 193(2):279\u2013290","journal-title":"Exp Neurol"},{"issue":"Suppl 2","key":"1868_CR63","doi-asserted-by":"publisher","first-page":"S1335","DOI":"10.4103\/jpbs.jpbs_586_23","volume":"16","author":"S Harshini","year":"2024","unstructured":"Harshini S, Shanmugam R, Govindharaj S (2024) Green synthesis of Mimosa pudica-mediated strontium nanoparticles and its anti-inflammatory activity. J Pharm Bioallied Sci 16(Suppl 2):S1335\u2013S1339","journal-title":"J Pharm Bioallied Sci"},{"key":"1868_CR64","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuint.2017.11.003","volume":"119","author":"H Hashimoto","year":"2018","unstructured":"Hashimoto H, Jiang W, Yoshimura T, Moon KH, Bok J, Ikenaka K (2018) Sonic hedgehog signaling in mouse ventral spinal cord. Neurochem Int 119:178\u2013183","journal-title":"Neurochem Int"},{"issue":"4","key":"1868_CR65","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson\u2019s disease: A target for neuroprotection? Lancet Neurol 8(4):382\u2013397","journal-title":"Lancet Neurol"},{"key":"1868_CR66","doi-asserted-by":"publisher","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","volume":"18","author":"EC Hirsch","year":"2012","unstructured":"Hirsch EC, Vyas S, Hunot S (2012) Neuroinflammation in Parkinson\u2019s disease. Parkinsonism Relat Disord 18:S210\u2013S212","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"1868_CR67","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.neuro.2009.08.012","volume":"30","author":"R Hosamani","year":"2009","unstructured":"Hosamani R, Muralidhara (2009) Neuroprotective efficacy of Bacopa monnieri against rotenone-induced oxidative stress and neurotoxicity in mice. Neurotoxicology 30(6):977\u2013985","journal-title":"Neurotoxicology"},{"issue":"4","key":"1868_CR69","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.apsb.2017.02.004","volume":"7","author":"C Huang","year":"2017","unstructured":"Huang C, Zhang H, Bai R (2017) Advances in ultrasound-targeted microbubble-mediated gene therapy. Acta Pharm Sin B 7(4):447\u2013452","journal-title":"Acta Pharm Sin B"},{"key":"1868_CR70","first-page":"1038","volume":"46","author":"A Hussain","year":"2018","unstructured":"Hussain A, Mishra V, Kumar P et al (2018) Recent advances in delivery of herbal drugs for the treatment of Parkinson\u2019s disease. Artif Cells Nanomed Biotechnol 46:1038\u20131050","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"3","key":"1868_CR68","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s11239-019-01945-3","volume":"48","author":"Y Hu","year":"2019","unstructured":"Hu Y, Wang J (2019) Interactions between clopidogrel and traditional Chinese medicine. J Thromb Thrombolysis 48(3):491\u2013499","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"1868_CR71","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.bbrc.2011.09.010","volume":"413","author":"P Jadiya","year":"2011","unstructured":"Jadiya P, Khan A, Sammi SR, Kaur S, Mir SS, Nazir A (2011) Anti-Parkinsonian effects of Bacopa monnieri in Caenorhabditis elegans models. Biochem Biophys Res Commun 413(4):605\u2013610","journal-title":"Biochem Biophys Res Commun"},{"key":"1868_CR72","doi-asserted-by":"crossref","unstructured":"Jamshidi N, Cohen MM (2017) The clinical efficacy and safety of Tulsi in humans: A systematic review of the literature. Evid. Based Complement. Alternat. Med. 2017, 9217567","DOI":"10.1155\/2017\/9217567"},{"issue":"5","key":"1868_CR74","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00204-015-1460-6","volume":"89","author":"DA Johnson","year":"2015","unstructured":"Johnson DA, Johnson JA (2015) The role of the Nrf2-ARE pathway in maintaining mitochondrial health and setting a threshold for apoptosis. Arch Toxicol 89(5):659\u2013674","journal-title":"Arch Toxicol"},{"key":"1868_CR75","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.colsurfb.2013.09.055","volume":"114","author":"S Jose","year":"2014","unstructured":"Jose S, Sowmya S, Cinu TA, Aleykutty NA, Thomas S, Souto EB (2014) Surface modified PLGA nanoparticles for brain targeting of Bacopa monnieri extract: Preparation and in vivo evaluation. Colloids Surf B Biointerfaces 114:144\u2013151","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1868_CR76","first-page":"1","volume":"2021","author":"T Joshi","year":"2021","unstructured":"Joshi T et al (2021) Targeting Parkinson\u2019s disease with plant-derived natural products: Recent advances and future perspectives. Oxid Med Cell Longev 2021:1\u201326","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"1868_CR77","first-page":"157","volume":"9","author":"HW Jung","year":"2009","unstructured":"Jung HW, Mahesh R, Park JH, Lee JG, Lee SH, Kim YK, Park YK (2009a) Inhibition of nitric oxide and prostaglandin E\u2082 production by Emblica officinalis in LPS-stimulated macrophages via suppression of NF-\u03baB and MAPK pathways. Int Immunopharmacol 9(2):157\u2013165","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"1868_CR78","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.fct.2009.02.012","volume":"47","author":"HW Jung","year":"2009","unstructured":"Jung HW, Yoon CH, Park KM, Han HS, Park YK (2009b) Hexane extract of Zingiber officinale attenuates pro-inflammatory cytokine production via inhibition of NF-\u03baB activation in lipopolysaccharide-stimulated microglia. Food Chem Toxicol 47(6):1190\u20131197","journal-title":"Food Chem Toxicol"},{"issue":"9996","key":"1868_CR79","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386(9996):896\u2013912","journal-title":"Lancet"},{"key":"1868_CR80","doi-asserted-by":"publisher","first-page":"954541","DOI":"10.3389\/fnmol.2022.954541","volume":"15","author":"B Kaltschmidt","year":"2022","unstructured":"Kaltschmidt B, Helweg LP, Greiner JFW, Kaltschmidt C (2022) NF-\u03baB in neurodegenerative diseases: Recent evidence from human genetics. Front Mol Neurosci 15:954541","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"1868_CR81","first-page":"125","volume":"7","author":"G Kaur","year":"2019","unstructured":"Kaur G, Invally M, Khan MK, Jadhav P (2019) Development of nanoformulated Bacopa monnieri extract: Improved cognitive function and antioxidant status in experimental models. Pharm Nanatechnol 7(2):125\u2013134","journal-title":"Pharm Nanatechnol"},{"issue":"1","key":"1868_CR82","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.brainres.2004.06.038","volume":"1021","author":"F Kehl","year":"2004","unstructured":"Kehl F, Payne RS, Roewer N, Schurr A (2004) Sevoflurane-induced preconditioning of rat brain in vitro and the role of KATP channels. Brain Res 1021(1):76\u201381","journal-title":"Brain Res"},{"key":"1868_CR85","doi-asserted-by":"publisher","first-page":"809621","DOI":"10.3389\/fnut.2022.809621","volume":"9","author":"N Khandouzi","year":"2022","unstructured":"Khandouzi N et al (2022) Potential role of ginger in the prevention of neurodegenerative diseases. Front Nutr 9:809621","journal-title":"Front Nutr"},{"issue":"1","key":"1868_CR83","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/nu11010039","volume":"11","author":"N Khan","year":"2018","unstructured":"Khan N, Mukhtar H (2018) Tea polyphenols in promotion of human health. Nutrients 11(1):39","journal-title":"Nutrients"},{"key":"1868_CR84","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.2147\/IJN.S368458","volume":"17","author":"S Khan","year":"2022","unstructured":"Khan S et al (2022) Green-synthesized nanoparticles and herbal medicine: A promising approach in neurodegenerative disease treatment. Int J Nanomed 17:1065\u20131090","journal-title":"Int J Nanomed"},{"issue":"3","key":"1868_CR86","doi-asserted-by":"publisher","first-page":"e80248","DOI":"10.7759\/cureus.80248","volume":"17","author":"S Khurana","year":"2025","unstructured":"Khurana S, Gourie-Devi M (2025) A Narrative Review of Community-Based Epidemiological Studies on Parkinson\u2019s Disease in India. Cureus 17(3):e80248. https:\/\/doi.org\/10.7759\/cureus.80248","journal-title":"Cureus"},{"issue":"12","key":"1868_CR87","first-page":"1186","volume":"12","author":"K Kieburtz","year":"2013","unstructured":"Kieburtz K, Wunderle KB (2013) Parkinson\u2019s disease: Evidence for environmental etiology. Lancet Neurol 12(12):1186\u20131197","journal-title":"Lancet Neurol"},{"issue":"11","key":"1868_CR88","first-page":"953","volume":"17","author":"S Kondoh","year":"2018","unstructured":"Kondoh S, Mizuno Y, Kondo T (2018) Randomized trial of istradefylline for Parkinson\u2019s disease patients with motor fluctuations. Lancet Neurol 17(11):953\u2013964","journal-title":"Lancet Neurol"},{"issue":"1","key":"1868_CR89","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1515\/JBCPP.2010.21.1.93","volume":"21","author":"M Krishnaveni","year":"2010","unstructured":"Krishnaveni M, Mirunalini S (2010) Therapeutic potential of Phyllanthus emblica (amla): The Ayurvedic wonder. J Basic Clin Physiol Pharmacol 21(1):93\u2013105","journal-title":"J Basic Clin Physiol Pharmacol"},{"issue":"7","key":"1868_CR90","first-page":"590","volume":"20","author":"T Kuboyama","year":"2006","unstructured":"Kuboyama T, Tohda C, Komatsu K (2006) Withanoside IV and VI from Withania somnifera improve cognitive dysfunction and neuronal loss. Phytother Res 20(7):590\u2013595","journal-title":"Phytother Res"},{"key":"1868_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1573407216999201113121756","volume":"17","author":"R Kumar","year":"2021","unstructured":"Kumar R, Garg R, Khurana N (2021) A comparative in vivo evaluation of anti-Alzheimer activity of Bacopa extract and its solid lipid nanoparticles. Curr Bioact Compd 17:1\u20138","journal-title":"Curr Bioact Compd"},{"key":"1868_CR92","doi-asserted-by":"publisher","first-page":"239","DOI":"10.5625\/lar.2018.34.4.239","volume":"34","author":"HJ Kwon","year":"2018","unstructured":"Kwon HJ, Jung HY, Hahn KR, Kim W, Kim JW, Yoo DY, Yoon YS, Hwang IK, Kim DW (2018) Bacopa monnieri extract improves novel object recognition, cell proliferation, neuroblast differentiation, brain-derived neurotrophic factor, and phosphorylation of cAMP response element-binding protein in the dentate gyrus. Lab Anim Res 34:239\u2013247","journal-title":"Lab Anim Res"},{"issue":"4","key":"1868_CR93","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/pharmaceutics16040514","volume":"16","author":"S Lapmanee","year":"2024","unstructured":"Lapmanee S, Bhubhanil S, Wongchitrat P, Charoenphon N, Inchan A, Ngernsutivorakul T et al (2024) Cannabidiol lipid nanoparticles alleviate metabolic and memory impairments in diabetic Parkinson\u2019s rats. Pharmaceutics 16(4):514","journal-title":"Pharmaceutics"},{"key":"1868_CR94","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3406","volume":"14","author":"HA Lashuel","year":"2013","unstructured":"Lashuel HA, Overk CR, Oueslati A, Masliah E (2013) The many faces of \u03b1-synuclein: From structure and toxicity to therapeutic target. Nat Rev Neurosci 14:38\u201348","journal-title":"Nat Rev Neurosci"},{"key":"1868_CR95","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.nbd.2004.11.009","volume":"19","author":"I Lastres-Becker","year":"2005","unstructured":"Lastres-Becker I, Molina-Holgado F, Ramos JA, Mechoulam R, Fern\u00e1ndez-Ruiz J (2005) Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity. Neurobiol Dis 19:96\u2013107","journal-title":"Neurobiol Dis"},{"issue":"20","key":"1868_CR96","first-page":"14158","volume":"283","author":"HJ Lee","year":"2008","unstructured":"Lee HJ, Suk JE, Bae EJ, Lee SJ (2008) Clearance and deposition of extracellular \u03b1-synuclein aggregates in microglia. J Biol Chem 283(20):14158\u201314169","journal-title":"J Biol Chem"},{"key":"1868_CR97","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1042\/BJ20111451","volume":"441","author":"J Lee","year":"2012","unstructured":"Lee J, Giordano S, Zhang J (2012) Autophagy, mitochondria, and oxidative stress: cross-talk and redox signalling. Biochem J 441:523\u2013540","journal-title":"Biochem J"},{"issue":"6","key":"1868_CR98","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3390\/plants13060771","volume":"13","author":"V Lerose","year":"2024","unstructured":"Lerose V, Ponticelli M, Benedetto N, Carlucci V, Lela L, Tzvetkov NT et al (2024) Withania somnifera (L.) Dunal, a potential source of phytochemicals for treating neurodegenerative diseases: a systematic review. Plants 13(6):771","journal-title":"Plants"},{"issue":"8","key":"1868_CR99","first-page":"949","volume":"16","author":"Y Levites","year":"2002","unstructured":"Levites Y et al (2002) Neuroprotection by green tea polyphenol EGCG in Parkinson\u2019s models. FASEB J 16(8):949\u2013951","journal-title":"FASEB J"},{"key":"1868_CR100","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.msec.2019.04.009","volume":"96","author":"C Li","year":"2019","unstructured":"Li C, Zhang J (2019) Development of a brain-targeted curcumin delivery system based on neutral-charged PEGylated solid lipid nanoparticles. Mater Sci Engineering: C 96:513\u2013521","journal-title":"Mater Sci Engineering: C"},{"key":"1868_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2013.00033","volume":"4","author":"KL Lim","year":"2013","unstructured":"Lim KL, Zhang CW (2013) Molecular events underlying Parkinson\u2019s disease \u2013 an interwoven tapestry. Front Neurol 4:1\u201312","journal-title":"Front Neurol"},{"issue":"5","key":"1868_CR101","first-page":"588","volume":"12","author":"P Li","year":"2014","unstructured":"Li P, Ho W, Chan W, Law C, Wong C, Siu T et al (2014) Antioxidant, anti-inflammatory and neuroprotective behaviors of Phyllanthus emblica fruit extracts. Mar Drugs 12(5):588\u2013601","journal-title":"Mar Drugs"},{"issue":"1\u20133","key":"1868_CR105","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46(1\u20133):3\u201326","journal-title":"Adv Drug Deliv Rev"},{"key":"1868_CR106","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.neulet.2015.04.034","volume":"604","author":"Y Liu","year":"2015","unstructured":"Liu Y, Zhang J, Zheng Y, Feng N (2015) Ginsenoside Rd protects dopaminergic neurons against neurotoxicity in experimental Parkinson\u2019s disease models. Neurosci Lett 604:97\u2013102","journal-title":"Neurosci Lett"},{"key":"1868_CR102","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.fitote.2012.12.009","volume":"84","author":"XZ Li","year":"2013","unstructured":"Li XZ, Zhang SN, Liu SM, Lu F (2013) Recent advances in herbal medicines treating Parkinson\u2019s disease. Fitoterapia 84:273\u2013285","journal-title":"Fitoterapia"},{"key":"1868_CR103","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12951-024-02351-5","volume":"22","author":"Y Li","year":"2024","unstructured":"Li Y, Zhang H, Wang X, Chen Y, Liu Z (2024) Microfluidics-enabled neuron-like cell membrane-coated curcumin nanoparticles alleviate neuroinflammation and apoptosis in Parkinson\u2019s disease models. J Nanobiotechnol 22:87","journal-title":"J Nanobiotechnol"},{"issue":"4","key":"1868_CR108","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1755-5949.2008.00060.x","volume":"14","author":"SA Mandel","year":"2008","unstructured":"Mandel SA et al (2008) Manipulation of multiple brain targets by green tea catechins. CNS Neurosci Ther 14(4):352\u2013365","journal-title":"CNS Neurosci Ther"},{"issue":"6","key":"1868_CR109","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3390\/foods8060185","volume":"8","author":"QQ Mao","year":"2019","unstructured":"Mao QQ et al (2019) Bioactive compounds and bioactivities of ginger (Zingiber officinale Roscoe). Foods 8(6):185","journal-title":"Foods"},{"key":"1868_CR110","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/03946320110240S203","volume":"24","author":"M Martinelli","year":"2011","unstructured":"Martinelli M, Carinci F, Morselli PG, Palmieri A, Girardi A, Riberti C et al (2011) No association between polymorphisms in Cubilin and the risk of non-syndromic cleft lip with or without cleft palate. Int J Immunopathol Pharmacol 24:11\u201314","journal-title":"Int J Immunopathol Pharmacol"},{"key":"1868_CR111","first-page":"28","volume":"29","author":"D Mathur","year":"2022","unstructured":"Mathur D, Gupta KK, Kumar V et al (2022) The molecular links of re-emerging therapy: a review of evidence of Brahmi (Bacopa monniera). Ann Neurosci 29:28\u201337","journal-title":"Ann Neurosci"},{"key":"1868_CR107","doi-asserted-by":"crossref","unstructured":"Ma X, Chen T, Ge R, Cui C, Xu F, Lv Q (2022) Time series-based PM2.5 concentration prediction in Jing-Jin-Ji area using machine learning algorithm models. Heliyon 8, e10691","DOI":"10.1016\/j.heliyon.2022.e10691"},{"issue":"1","key":"1868_CR112","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1006\/exnr.2002.8050","volume":"179","author":"KS McNaught","year":"2003","unstructured":"McNaught KS, Belizaire R, Isacson O, Jenner P, Olanow CW (2003) Altered proteasomal function in sporadic Parkinson\u2019s disease. Exp Neurol 179(1):38\u201346","journal-title":"Exp Neurol"},{"key":"1868_CR113","doi-asserted-by":"publisher","first-page":"116176","DOI":"10.1016\/j.molliq.2021.116176","volume":"336","author":"VK Meena","year":"2021","unstructured":"Meena VK, Kumar V, Karalia S (2021) Inhibitory effect of Ocimum sanctum extract on \u03b1-synuclein aggregation. J Mol Liq 336:116176","journal-title":"J Mol Liq"},{"issue":"4","key":"1868_CR114","first-page":"334","volume":"5","author":"LC Mishra","year":"2000","unstructured":"Mishra LC, Singh BB, Dagenais S (2000) Scientific basis for the therapeutic use of Withania somnifera (Ashwagandha): A review. Altern Med Rev 5(4):334\u2013346","journal-title":"Altern Med Rev"},{"key":"1868_CR115","doi-asserted-by":"crossref","unstructured":"Mohd Sahardi NFN, Makpol S (2019) Ginger (Zingiber officinale Roscoe) in the prevention of ageing and degenerative diseases. Evid. Based Complement. Alternat. Med. 2019, 1\u201313","DOI":"10.1155\/2019\/5054395"},{"issue":"4","key":"1868_CR116","first-page":"291","volume":"53","author":"S Mondal","year":"2009","unstructured":"Mondal S, Mirdha BR, Mahapatra SC (2009) The science behind sacredness of Tulsi (Ocimum sanctum Linn). Indian J Physiol Pharmacol 53(4):291\u2013306","journal-title":"Indian J Physiol Pharmacol"},{"issue":"10","key":"1868_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/ejmp\/2023\/v34i61140","volume":"34","author":"MN Murthy","year":"2023","unstructured":"Murthy MN, Chandana V, Nisarga HD, Shyamala BV (2023) The ameliorative effect of Ashwagandha\u2014Withania somnifera (L.) Dunal on park\u00b2\u2075 induced neurodegeneration in Drosophila melanogaster Parkinson\u2019s disease model. Eur J Med Plants 34(10):1\u201312","journal-title":"Eur J Med Plants"},{"issue":"3","key":"1868_CR117","doi-asserted-by":"publisher","first-page":"38","DOI":"10.9734\/jocamr\/2023\/v22i3461","volume":"22","author":"MN Murthy","year":"2023","unstructured":"Murthy MN, Shyamala BV (2023) Human tau E14 mutation induced neurodegeneration in Drosophila melanogaster is ameliorated by developmental supplement of Withania somnifera root extract. J Complement Altern Med Res 22(3):38\u201347","journal-title":"J Complement Altern Med Res"},{"key":"1868_CR118","doi-asserted-by":"publisher","first-page":"116897","DOI":"10.1016\/j.jep.2023.116897","volume":"318","author":"MN Murthy","year":"2024","unstructured":"Murthy MN, Shyamala BV (2024) Ashwagandha \u2013 Withania somnifera (L.) Dunal as a multipotent neuroprotective remedy for genetically induced motor dysfunction and cellular toxicity in human neurodegenerative disease models of Drosophila. J Ethnopharmacol 318:116897","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"1868_CR121","first-page":"412","volume":"17","author":"RB Mythri","year":"2011","unstructured":"Mythri RB, Bharath MMS (2011) Neuroprotective properties of curcumin in toxin-based animal models of Parkinson\u2019s disease: A systematic review. BMC Complement Altern Med 17(1):412","journal-title":"BMC Complement Altern Med"},{"issue":"1","key":"1868_CR120","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2174\/138161212798918995","volume":"18","author":"RB Mythri","year":"2012","unstructured":"Mythri RB, Bharath MMS (2012) Curcumin: A potential neuroprotective agent in Parkinson\u2019s disease. Curr Pharm Design 18(1):91\u201399","journal-title":"Curr Pharm Design"},{"key":"1868_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresbull.2015.09.002","volume":"119","author":"SF Nabavi","year":"2015","unstructured":"Nabavi SF, Braidy N, Gortzi O, Sobarzo-S\u00e1nchez E, Daglia M, Skalicka-Wo\u017aniak K, Nabavi SM (2015) Luteolin as an anti-inflammatory and neuroprotective agent: A brief review. Brain Res Bull 119:1\u201311","journal-title":"Brain Res Bull"},{"issue":"2","key":"1868_CR123","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0022-510X(00)00329-4","volume":"176","author":"N Nagashayana","year":"2000","unstructured":"Nagashayana N, Sankarankutty P, Nampoothiri M, Kurup P, Mohan Kumar K, Mohanakumar K (2000) Association of L-DOPA with recovery following Ayurvedic medication in Parkinson\u2019s disease. J Neurol Sci 176(2):124\u2013127","journal-title":"J Neurol Sci"},{"key":"1868_CR124","doi-asserted-by":"publisher","first-page":"113122","DOI":"10.1016\/j.biopha.2022.113122","volume":"151","author":"A Nath","year":"2022","unstructured":"Nath A, Bhattacharjee R, Nandi A, Sinha A, Kar S, Manoharan N et al (2022) Phage delivered CRISPR-Cas system to combat multidrug-resistant pathogens in gut microbiome. Biomed Pharmacother 151:113122","journal-title":"Biomed Pharmacother"},{"key":"1868_CR125","doi-asserted-by":"crossref","unstructured":"Nellore J, Pauline C, Amarnath K (2013) Bacopa monnieri phytochemicals mediated synthesis of platinum nanoparticles and its neurorescue effect on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced experimental parkinsonism in zebrafish. J. Neurodegener. Dis. 2013, 972391","DOI":"10.1155\/2013\/972391"},{"key":"1868_CR126","first-page":"4719","volume":"9","author":"S Ojha","year":"2015","unstructured":"Ojha S, Jha S (2015) Plant polyphenols and neurodegenerative disorders. Drug Des Devel Ther 9:4719\u20134735","journal-title":"Drug Des Devel Ther"},{"key":"1868_CR127","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s41936-025-00484-z","volume":"86","author":"S Pal","year":"2025","unstructured":"Pal S, Tarafder B, Dey D, Firdous SM (2025) Neurobehavioral effects and brain GFAP modulation by Mimosa pudica extract in zebrafish exposed to zinc oxide nanoparticles. J Basic Appl Zool 86:64","journal-title":"J Basic Appl Zool"},{"issue":"4","key":"1868_CR128","first-page":"199","volume":"9","author":"N Pankratz","year":"2007","unstructured":"Pankratz N, Foroud T (2007) Genetics of Parkinson disease. Genet Sci 9(4):199\u2013211","journal-title":"Genet Sci"},{"key":"1868_CR129","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ijpharm.2007.06.005","volume":"343","author":"E Park","year":"2007","unstructured":"Park E, Na D, Lee K (2007) In vitro release study of mono-PEGylated growth hormone-releasing peptide-6 from PLGA microspheres. Int J Pharm 343:281\u2013283","journal-title":"Int J Pharm"},{"key":"1868_CR130","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.neuropharm.2014.10.014","volume":"89","author":"M Pascual","year":"2015","unstructured":"Pascual M, Bali\u00f1o P, Arag\u00f3n CMG, Guerri C (2015) Cytokines as biomarkers of ethanol-induced neuroinflammation. Neuropharmacol 89:352\u2013359","journal-title":"Neuropharmacol"},{"key":"1868_CR131","doi-asserted-by":"crossref","unstructured":"Patel A, Olang CA, Lewis G, Mandalaneni K, Anand N, Gorantla VR (2022) An overview of Parkinson\u2019s disease: Curcumin as a possible alternative treatment. Cureus","DOI":"10.7759\/cureus.25032"},{"issue":"1","key":"1868_CR132","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3126\/arj.v5i1.73553","volume":"5","author":"I Pathak","year":"2024","unstructured":"Pathak I, Niraula M, Sharma KR, Thapa P, Oli HB, Kalauni SK (2024) Green synthesis of silver nanoparticles from Ocimum sanctum Linn. and their antioxidant activity. Amrit Res J 5(1):82\u201390","journal-title":"Amrit Res J"},{"key":"1868_CR133","first-page":"696","volume":"6","author":"G Patro","year":"2016","unstructured":"Patro G, Behera SM (2016) Effects of Mimosa pudica L. leaves extract on anxiety, depression, and memory. Avicenna J Phytomed 6:696\u2013710","journal-title":"Avicenna J Phytomed"},{"issue":"7","key":"1868_CR134","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4103\/0973-7847.65323","volume":"4","author":"P Pattanayak","year":"2010","unstructured":"Pattanayak P, Behera P, Das D, Panda SK (2010) Ocimum sanctum Linn. A reservoir plant for therapeutic applications: An overview. Pharmacogn Rev 4(7):95\u2013105","journal-title":"Pharmacogn Rev"},{"key":"1868_CR135","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3389\/fphar.2018.00482","volume":"9","author":"FF Peres","year":"2018","unstructured":"Peres FF, Lima AC, Hallak JEC, Crippa JA, Silva RH, Ab\u00edlio VC (2018) Cannabidiol as a promising strategy to treat and prevent movement disorders? Front Pharmacol 9:482","journal-title":"Front Pharmacol"},{"issue":"S1","key":"1868_CR136","doi-asserted-by":"publisher","first-page":"S163","DOI":"10.1038\/sj.bjp.0706406","volume":"147","author":"RG Pertwee","year":"2006","unstructured":"Pertwee RG (2006) Cannabinoid pharmacology: the first 66 years. Br J Pharmacol 147(S1):S163\u2013S171","journal-title":"Br J Pharmacol"},{"key":"1868_CR137","doi-asserted-by":"crossref","unstructured":"Peth-Nui T, Wattanathorn J, Muchimapura S, Tong-Un T, Wannanon P, Bunterm T, Jittiwat J (2012) Effects of Bacopa monnieri on cognitive performance and blood cholinesterase activity in healthy elderly volunteers. Evid. Based Complement. Alternat. Med. 2012, 606424","DOI":"10.1155\/2012\/606424"},{"issue":"1","key":"1868_CR138","first-page":"6405987","volume":"2021","author":"S Phochantachinda","year":"2021","unstructured":"Phochantachinda S, Chatchaisak D, Temviriyanukul P, Chansawang A, Pitchakarn P, Chantong B (2021) Ethanolic fruit extract of Emblica officinalis suppresses neuroinflammation in microglia and promotes neurite outgrowth in Neuro2a cells. Evidence-Based Complement Altern Med 2021(1):6405987","journal-title":"Evidence-Based Complement Altern Med"},{"issue":"9","key":"1868_CR139","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DEV Pires","year":"2015","unstructured":"Pires DEV, Blundell TL, Ascher DB (2015) pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 58(9):4066\u20134072","journal-title":"J Med Chem"},{"key":"1868_CR140","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"K Poewe","year":"2017","unstructured":"Poewe K, Seppi CM, Tanner CM, Halliday GM, Brundin P, Volkmann J et al (2017) Parkinson disease. Nat Rev Dis Primers 3:17013","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"1868_CR141","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.addr.2007.10.010","volume":"60","author":"CW Pouton","year":"2008","unstructured":"Pouton CW, Porter CJH (2008) Formulation of lipid-based delivery systems for oral administration. Adv Drug Deliv Rev 60(6):625\u2013637","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"1868_CR142","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1007\/s11064-014-1443-7","volume":"39","author":"J Prakash","year":"2014","unstructured":"Prakash J, Chouhan S, Yadav SK, Westfall S, Rai SN, Singh SP (2014a) Withania somnifera alleviates Parkinsonian phenotypes by inhibiting apoptotic pathways in dopaminergic neurons. Neurochem Res 39(12):2527\u20132536","journal-title":"Neurochem Res"},{"issue":"1","key":"1868_CR143","first-page":"103","volume":"50","author":"J Prakash","year":"2014","unstructured":"Prakash J, Chouhan S, Yadav SK, Westfall S, Rai SN, Singh SP (2014b) Withania somnifera (Ashwagandha) alleviates neuropsychological, bioenergetics, and oxidative stress markers in an MPTP-induced mouse model of Parkinson\u2019s disease. Mol Neurobiol 50(1):103\u2013115","journal-title":"Mol Neurobiol"},{"issue":"2","key":"1868_CR144","first-page":"125","volume":"49","author":"P Prakash","year":"2005","unstructured":"Prakash P, Gupta N (2005) Therapeutic uses of Ocimum sanctum Linn (Tulsi) with a note on eugenol and its pharmacological actions: A short review. Indian J Physiol Pharmacol 49(2):125\u2013131","journal-title":"Indian J Physiol Pharmacol"},{"key":"1868_CR145","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim T, Jette N, Frolkis A, Steeves TDL (2014) The prevalence of Parkinson\u2019s disease: A systematic review and meta-analysis. Mov Disord 29:1583\u20131590","journal-title":"Mov Disord"},{"issue":"1","key":"1868_CR146","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/bioengineering10010064","volume":"10","author":"P Rachitha","year":"2023","unstructured":"Rachitha P, Krishnaswamy K, Lazar RA, Gupta VK, Inbaraj BS, Raghavendra VB et al (2023) Attenuation of hyperlipidemia by Emblica officinalis with nanotechnological approaches. Bioengineering 10(1):64","journal-title":"Bioengineering"},{"issue":"3","key":"1868_CR147","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1254\/jphs.CRJ05010X","volume":"100","author":"K Radad","year":"2006","unstructured":"Radad K, Gille G, Liu L, Rausch WD (2006) Use of ginseng in medicine with emphasis on neurodegenerative disorders. J Pharmacol Sci 100(3):175\u2013186","journal-title":"J Pharmacol Sci"},{"issue":"9","key":"1868_CR148","first-page":"13721","volume":"234","author":"HR Rahimi","year":"2019","unstructured":"Rahimi HR, Mohammadpour AH, Dastani M, Mehrzad J (2019) Curcumin-loaded nanoparticles: A novel therapeutic strategy in treatment of central nervous system disorders. J Cell Physiol 234(9):13721\u201313735","journal-title":"J Cell Physiol"},{"issue":"11","key":"1868_CR149","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.3390\/molecules27113561","volume":"27","author":"AH Rahmani","year":"2022","unstructured":"Rahmani AH et al (2022) Therapeutic role of active components of ginger in disease prevention via modulation of various biological activities. Molecules 27(11):3561","journal-title":"Molecules"},{"issue":"4","key":"1868_CR150","first-page":"2006","volume":"56","author":"SN Rai","year":"2019","unstructured":"Rai SN, Diliramlo G, Birla H, Singh SS, Zahra W, Keswani C, Singh SP (2019) The role of PI3K\/Akt and ERK\/MAPK pathways in neurodegeneration as a target for therapeutic intervention. Mol Neurobiol 56(4):2006\u20132021","journal-title":"Mol Neurobiol"},{"issue":"2","key":"1868_CR151","first-page":"424","volume":"148","author":"G Rakotomalala","year":"2013","unstructured":"Rakotomalala G, Agard C, Tonnerre P, Tesse A, Derbr\u00e9 S, Michalet S, Hamel A, Heymann MF (2013) Extract from Mimosa pudica exerts anti-inflammatory and antioxidant effects. J Ethnopharmacol 148(2):424\u2013432","journal-title":"J Ethnopharmacol"},{"key":"1868_CR152","first-page":"4957","volume":"10","author":"S Ramasamy","year":"2015","unstructured":"Ramasamy S, Kiew LV, Chung LY, Ratnam DV (2015) Lipid-based nanocarriers for brain-targeted delivery of herbal extracts: Enhanced neuroprotective potential of Bacopa monnieri. Int J Nanomed 10:4957\u20134970","journal-title":"Int J Nanomed"},{"key":"1868_CR153","first-page":"615","volume":"23","author":"U Rao","year":"2020","unstructured":"Rao U, Rana A, Virmani T (2020) Parkinson\u2019s disease and its rising burden in India. Ann Indian Acad Neurol 23:615\u2013618","journal-title":"Ann Indian Acad Neurol"},{"issue":"12","key":"1868_CR154","first-page":"1016","volume":"20","author":"M Rivera-Oliver","year":"2014","unstructured":"Rivera-Oliver M, D\u00edaz-R\u00edos M (2014) Using caffeine and adenosine receptor antagonists to treat neurodegenerative diseases: A review. CNS Neurosci Ther 20(12):1016\u20131025","journal-title":"CNS Neurosci Ther"},{"key":"1868_CR155","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2014.00328","volume":"8","author":"GM Rojas","year":"2014","unstructured":"Rojas GM, G\u00e1lvez M, Vega-Potler N, Craddock RC, Margulies DS, Castellanos FX et al (2014) Stereoscopic three-dimensional visualization applied to multimodal brain images: clinical applications and a functional connectivity atlas. Front Neurosci 8:1\u201312","journal-title":"Front Neurosci"},{"key":"1868_CR157","doi-asserted-by":"publisher","first-page":"116302","DOI":"10.1016\/j.envres.2023.116302","volume":"232","author":"S Sadeghi","year":"2023","unstructured":"Sadeghi S, Esmaeili A, Zarrabi A (2023) Dextran-coated iron oxide nanoparticles in combination with ginger extract promote neurite outgrowth and PC12 cell branching. Environ Res 232:116302","journal-title":"Environ Res"},{"key":"1868_CR156","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1021\/acschemneuro.8b00510","volume":"10","author":"S Sadegh Malvajerd","year":"2019","unstructured":"Sadegh Malvajerd S, Azadi A, Izadi Z, Kurd M, Dara T, Dibaei M et al (2019) Brain delivery of curcumin using solid lipid nanoparticles and nanostructured lipid carriers. ACS Chem Neurosci 10:728\u2013739","journal-title":"ACS Chem Neurosci"},{"key":"1868_CR158","first-page":"100704","volume":"4","author":"CV Saji","year":"2024","unstructured":"Saji CV, Mohanakumar KP, Shenoi RA (2024a) Phytochemicals in the management of Parkinson\u2019s disease: mechanistic insights and therapeutic potential. Phytomedicine Plus 4:100704","journal-title":"Phytomedicine Plus"},{"key":"1868_CR159","doi-asserted-by":"crossref","unstructured":"Saji CV, Mohanakumar KP, Shenoi RA (2024b) Phytomedicine nanoformulations for Parkinson\u2019s disease. Phytomedicine Plus. 100704","DOI":"10.1016\/j.phyplu.2024.100704"},{"key":"1868_CR160","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jsps.2023.01.002","volume":"31","author":"HS Sajwani","year":"2023","unstructured":"Sajwani HS (2023) The dilemma of new psychoactive substances: a growing threat. Saudi Pharm J 31:348\u2013350","journal-title":"Saudi Pharm J"},{"key":"1868_CR161","doi-asserted-by":"crossref","unstructured":"Samreen, Qais FA, Ahmad I (2022) Anti-quorum sensing and biofilm inhibitory effect of some medicinal plants against Gram-negative bacterial pathogens. Heliyon 8, e11113","DOI":"10.1016\/j.heliyon.2022.e11113"},{"issue":"2","key":"1868_CR162","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1159\/000495326","volume":"51","author":"Q Sang","year":"2018","unstructured":"Sang Q, Liu X (2018) Curcumin protects SH-SY5Y human neuroblastoma cells against MPP\u207a-induced toxicity via antioxidant and anti-apoptotic mechanisms. Cell Physiol Biochem 51(2):681\u2013691","journal-title":"Cell Physiol Biochem"},{"key":"1868_CR163","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2011\/159160","volume":"2011","author":"AHV Schapira","year":"2011","unstructured":"Schapira AHV, Gegg MM (2011) Mitochondrial contribution to Parkinson\u2019s disease pathogenesis. Parkinsons Dis 2011:1\u20137","journal-title":"Parkinsons Dis"},{"issue":"9","key":"1868_CR164","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1073\/pnas.1112209109","volume":"109","author":"N Sehgal","year":"2012","unstructured":"Sehgal N, Gupta A, Valli RK, Khanna SD, Mills JP, Hamel MC, Ravindranath V (2012) Withania somnifera reverses Alzheimer\u2019s disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc Natl Acad Sci U S A 109(9):3510\u20133515","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1868_CR165","doi-asserted-by":"publisher","first-page":"438","DOI":"10.2174\/1570159X16666180419123022","volume":"17","author":"VC Sekhar","year":"2019","unstructured":"Sekhar VC, Viswanathan G, Baby S (2019) Insights into the molecular aspects of neuroprotective Bacoside A and Bacopaside I. Curr Neuropharmacol 17:438\u2013446","journal-title":"Curr Neuropharmacol"},{"key":"1868_CR166","doi-asserted-by":"publisher","first-page":"25910","DOI":"10.1039\/D5RA03578C","volume":"15","author":"D Senanayake","year":"2025","unstructured":"Senanayake D, Yapa P, Dabare S, Munaweera I (2025) Precision targeting of the CNS: recent progress in brain-directed nanodrug delivery. RSC Adv 15:25910\u201325928","journal-title":"RSC Adv"},{"key":"1868_CR167","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2020.01021","volume":"11","author":"J Sharifi-Rad","year":"2020","unstructured":"Sharifi-Rad J, Rayess E, Rizk Y, Sadaka AA, Zgheib C, Zam R, W., et al (2020) Turmeric and its major compound curcumin on health: bioactive effects and safety profiles. Front Pharmacol 11:1\u201320","journal-title":"Front Pharmacol"},{"issue":"8","key":"1868_CR168","first-page":"2436","volume":"42","author":"S Sharma","year":"2017","unstructured":"Sharma S, Singh R, Bhatia J (2017) Neuroprotective and anti-neuroinflammatory effects of ginger in experimental models of Parkinson\u2019s disease. Neurochem Res 42(8):2436\u20132449","journal-title":"Neurochem Res"},{"issue":"2","key":"1868_CR169","first-page":"285","volume":"36","author":"GK Shinomol","year":"2011","unstructured":"Shinomol GK,Muralidhara (2011) Bacopa monnieri mitigates rotenone-induced oxidative stress and neurotoxicity in a Drosophila model of Parkinson\u2019s disease. Neurochem Res 36(2):285\u2013297","journal-title":"Neurochem Res"},{"issue":"10","key":"1868_CR170","first-page":"747","volume":"12","author":"YH Siddique","year":"2014","unstructured":"Siddique YH, Jyoti S, Mushir A, Faisal M, Al-Khedhairy AA (2014) Protective effect of Ocimum sanctum on the transgenic Drosophila model of Parkinson\u2019s disease. Chin J Nat Med 12(10):747\u2013753","journal-title":"Chin J Nat Med"},{"key":"1868_CR171","doi-asserted-by":"publisher","first-page":"5S","DOI":"10.4314\/ajtcam.v8i5S.9","volume":"8","author":"N Singh","year":"2011","unstructured":"Singh N, Bhalla M, De Jager P, Gilca M (2011) An overview on Ashwagandha: a Rasayana of Ayurveda. Afr J Tradit Complement Altern Med 8:5S","journal-title":"Afr J Tradit Complement Altern Med"},{"issue":"1","key":"1868_CR172","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/npp.2011.212","volume":"37","author":"Y Smith","year":"2012","unstructured":"Smith Y, Wichmann T, Factor SA, DeLong MR (2012) Parkinson\u2019s disease therapeutics: New developments and challenges since the introduction of levodopa. Neuropsychopharmacology 37(1):213\u2013246","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"1868_CR173","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.jep.2011.12.030","volume":"139","author":"JX Song","year":"2012","unstructured":"Song JX, Sze SCW, Ng TB, Lee CKF, Leung GPH, Shaw PC, Wong RNS, Zhang YB (2012) Anti-Parkinsonian drug discovery from herbal medicines: What have we got from neurotoxic models? J Ethnopharmacol 139(3):698\u2013711","journal-title":"J Ethnopharmacol"},{"issue":"Suppl 1","key":"1868_CR174","first-page":"S24","volume":"26","author":"F Stocchi","year":"2011","unstructured":"Stocchi F, Jenner P (2011) Challenges in the management of Parkinson\u2019s disease: the role of non-ergot dopamine agonists. Mov Disord 26(Suppl 1):S24\u2013S30","journal-title":"Mov Disord"},{"issue":"8","key":"1868_CR175","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3390\/pharmaceutics17080985","volume":"17","author":"S Stoeva-Grigorova","year":"2025","unstructured":"Stoeva-Grigorova S, Ivanova N, Sotirova Y, Radeva-Ilieva M, Hvarchanova N, Georgiev K (2025) Lipid-based nanotechnologies for delivery of green tea catechins. Pharmaceutics 17(8):985","journal-title":"Pharmaceutics"},{"key":"1868_CR176","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","volume":"106\u2013107","author":"SR Subramaniam","year":"2013","unstructured":"Subramaniam SR, Chesselet MF (2013) Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease. Prog Neurobiol 106\u2013107:17\u201332","journal-title":"Prog Neurobiol"},{"key":"1868_CR177","first-page":"2781","volume":"13","author":"N Suganthy","year":"2018","unstructured":"Suganthy N, Ponsamy PSG (2018) Protective role of EGCG nanoformulation against 6-OHDA-induced Parkinsonism in rats. Int J Nanomed 13:2781\u20132796","journal-title":"Int J Nanomed"},{"key":"1868_CR178","unstructured":"Tambasco N, Simoni S, Eusebi P, Ripandelli F, Brahimi E, Sacchini D, Calabresi P (2018) Clinical aspects and management of levodopa-induced dyskinesia. Parkinson\u2019s Disease 2018, 7459471"},{"key":"1868_CR179","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0733-8619(05)70259-0","volume":"14","author":"CM Tanner","year":"1996","unstructured":"Tanner CM, Goldman SM (1996) Epidemiology of Parkinson\u2019s disease. Neurol Clin 14:317\u2013335","journal-title":"Neurol Clin"},{"issue":"4","key":"1868_CR180","first-page":"251","volume":"10","author":"MG Tansey","year":"2010","unstructured":"Tansey MG, Goldberg MS (2010) Neuroinflammation in Parkinson\u2019s disease: Its role in neuronal death and therapeutic implications. Nat Rev Immunol 10(4):251\u2013267","journal-title":"Nat Rev Immunol"},{"key":"1868_CR181","first-page":"432","volume":"8","author":"MS Uddin","year":"2016","unstructured":"Uddin MS, Mamun AA, Hossain MS, Akter F, Iqbal MA, Asaduzzaman M (2016) Neuroprotective potential of Phyllanthus emblica L. fruit extract against MPTP-induced Parkinsonism in mice. Int J Pharm Pharm Sci 8:432\u2013438","journal-title":"Int J Pharm Pharm Sci"},{"key":"1868_CR182","doi-asserted-by":"publisher","first-page":"S1330","DOI":"10.4103\/jpbs.jpbs_588_23","volume":"16","author":"K Vallinayaki","year":"2024","unstructured":"Vallinayaki K, Shanmugam R, Munusamy T (2024) Biosynthesis of strontium nanoparticles using Mimosa pudica and its antioxidant effect. J Pharm Bioallied Sci 16:S1330\u2013S1334","journal-title":"J Pharm Bioallied Sci"},{"issue":"5","key":"1868_CR183","first-page":"688","volume":"30","author":"BC Variya","year":"2016","unstructured":"Variya BC, Bakrania AK, Patel SS (2016a) Emblica officinalis (Amla): A review for its phytochemistry, ethnomedicinal uses and medicinal potentials with respect to molecular mechanisms. Phytother Res 30(5):688\u2013712","journal-title":"Phytother Res"},{"key":"1868_CR185","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.phrs.2016.06.013","volume":"111","author":"BC Variya","year":"2016","unstructured":"Variya BC, Bakrania AK, Patel SS (2016b) Emblica officinalis (Amla): A review for its phytochemistry, ethnomedicinal uses and medicinal potentials with respect to molecular mechanisms. Pharmacol Res 111:180\u2013200","journal-title":"Pharmacol Res"},{"issue":"6","key":"1868_CR184","first-page":"1235","volume":"34","author":"BC Variya","year":"2020","unstructured":"Variya BC, Bakrania AK, Patel SS (2020) Emblica officinalis (Amla): Updated review on molecular mechanisms and therapeutic potential in neurodegenerative disorders. Phytother Res 34(6):1235\u20131252","journal-title":"Phytother Res"},{"issue":"1","key":"1868_CR186","first-page":"53","volume":"24","author":"R Verma","year":"2023","unstructured":"Verma R, Prasad R, Rajput S, Singh M, Ahmad A (2023) Nanotechnology approaches in Withania somnifera delivery for Parkinson\u2019s disease. Curr Drug Metab 24(1):53\u201363","journal-title":"Curr Drug Metab"},{"key":"1868_CR187","first-page":"2994","volume":"7","author":"S Waheed","year":"2020","unstructured":"Waheed S, Badoni H (2020) Anti-Parkinson\u2019s activity of Emblica officinalis and Terminalia bellirica. J Crit Rev 7:2994\u20133304","journal-title":"J Crit Rev"},{"key":"1868_CR188","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s12906-017-1922-x","volume":"17","author":"XS Wang","year":"2017","unstructured":"Wang XS, Zhang ZR, Zhang MM, Sun MX, Wang WW, Xie CL (2017) Neuroprotective properties of curcumin in toxin-based animal models of Parkinson\u2019s disease: a systematic experimental literature review. BMC Complement Altern Med 17:412","journal-title":"BMC Complement Altern Med"},{"issue":"7","key":"1868_CR189","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/nn.2575","volume":"13","author":"E Wong","year":"2010","unstructured":"Wong E, Cuervo AM (2010) Autophagy gone awry in neurodegenerative diseases. Nat Neurosci 13(7):805\u2013811","journal-title":"Nat Neurosci"},{"issue":"1","key":"1868_CR191","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","volume":"8","author":"LC Xu","year":"2023","unstructured":"Xu LC, Mu L, Hu X (2023) Signaling pathways in Parkinson\u2019s disease: molecular mechanisms and therapeutic interventions. Signal Transduct Target Therapy 8(1):73","journal-title":"Signal Transduct Target Therapy"},{"key":"1868_CR190","unstructured":"Xu L, Zhang Y, Zhang L et al (2021) Neuroprotective effects of ginsenosides on Parkinson\u2019s disease. Oxid. Med. Cell. Longev."},{"key":"1868_CR192","first-page":"1","volume":"13","author":"DK Yadav","year":"2022","unstructured":"Yadav DK, Kumar M, Pandey T et al (2022) Recent advances in phytopharmaceuticals for the treatment of neurodegenerative diseases: targeting oxidative stress and inflammation. Front Pharmacol 13:1\u201318","journal-title":"Front Pharmacol"},{"issue":"1","key":"1868_CR193","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40035-018-0120-1","volume":"1","author":"L Yang","year":"2011","unstructured":"Yang L, Calingasan NY, Thomas B, Chaturvedi RK, Kiaei M, Wille EJ, Beal MF (2011) Curcumin inhibition of JNKs prevents dopaminergic neuronal loss in a mouse model of Parkinson\u2019s disease. Transl Neurodegener 1(1):16","journal-title":"Transl Neurodegener"},{"issue":"1","key":"1868_CR194","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrm3028","volume":"12","author":"RJ Youle","year":"2011","unstructured":"Youle RJ, Narendra DP (2011) Mechanisms of mitophagy. Nat Rev Mol Cell Biol 12(1):9\u201314","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1868_CR195","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3389\/fnmol.2017.00312","volume":"10","author":"J Zhao","year":"2017","unstructured":"Zhao J, Zhang X, Cheng Y (2017) EGCG inhibits \u03b1-synuclein aggregation and reduces toxicity in human neuroblastoma cells. Front Mol Neurosci 10:312","journal-title":"Front Mol Neurosci"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01868-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-026-01868-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01868-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:04:06Z","timestamp":1779167046000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-026-01868-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":193,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1868"],"URL":"https:\/\/doi.org\/10.1007\/s11011-026-01868-y","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"22 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"101"}}